Unknown

Dataset Information

0

Caloric Restriction and Weight Loss Are Primary Factors in the Early Tissue-Specific Metabolic Changes After Bariatric Surgery.


ABSTRACT:

Objective

To evaluate changes in insulin sensitivity, hormone secretion, and hepatic steatosis immediately after caloric restriction, vertical sleeve gastrectomy (VSG), and Roux-en-Y gastric bypass (RYGB).

Research design and methods

Obese subjects were assessed for 1) insulin sensitivity with hyperinsulinemic-euglycemic clamp with glucose tracer infusion, 2) adipokine concentrations with serum and subcutaneous adipose interstitial fluid sampling, and 3) hepatic fat content with MRI before and 7-10 days after VSG, RYGB, or supervised caloric restriction.

Results

Each group exhibited an ∼5% total body weight loss, accompanied by similar improvements in hepatic glucose production and hepatic, skeletal muscle, and adipose tissue insulin sensitivity. Leptin concentrations in plasma and adipose interstitial fluid were equally decreased, and reductions in hepatic fat were similar.

Conclusions

The improvements in insulin sensitivity and adipokine secretion observed early after bariatric surgery are replicated by equivalent caloric restriction and weight loss.

SUBMITTER: Flynn CR 

PROVIDER: S-EPMC9346980 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Caloric Restriction and Weight Loss Are Primary Factors in the Early Tissue-Specific Metabolic Changes After Bariatric Surgery.

Flynn Charles Robb CR   Tamboli Robyn A RA   Antoun Joseph J   Sidani Reem M RM   Williams Brandon B   Spann Matthew D MD   English Wayne J WJ   Welch E Brian EB   Sundaresan Sinju S   Abumrad Naji N NN  

Diabetes care 20220801 8


<h4>Objective</h4>To evaluate changes in insulin sensitivity, hormone secretion, and hepatic steatosis immediately after caloric restriction, vertical sleeve gastrectomy (VSG), and Roux-en-Y gastric bypass (RYGB).<h4>Research design and methods</h4>Obese subjects were assessed for 1) insulin sensitivity with hyperinsulinemic-euglycemic clamp with glucose tracer infusion, 2) adipokine concentrations with serum and subcutaneous adipose interstitial fluid sampling, and 3) hepatic fat content with M  ...[more]

Similar Datasets

| S-EPMC7872092 | biostudies-literature
| S-EPMC8591680 | biostudies-literature
| S-EPMC2634841 | biostudies-literature
| S-EPMC10509516 | biostudies-literature
| PRJEB40616 | ENA
| S-EPMC3810417 | biostudies-literature
| S-EPMC9301317 | biostudies-literature
| S-EPMC4888907 | biostudies-literature
| S-EPMC10687127 | biostudies-literature
| S-EPMC4308947 | biostudies-literature